concept

FLAVONOIDS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FLAVONOIDS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

579Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

Summary

FLAVONOIDS is a concept in neurodegeneration research. Key relationships include: therapeutic target, activates, regulates. Associated with ALS, Aging, Als. Connected to 283 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	FLAVONOIDS
Key Genes/Proteins	ERK
Related Diseases	Als, Inflammation, Neurodegeneration, Cancer, Aging
Related Pathways	MAPK, Apoptosis

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    FLAVONOIDS["FLAVONOIDS"]
    FLAVONOIDS -->|"regulates"| ERK["ERK"]
    FLAVONOIDS -.protects against.-> oxidative_stress["oxidative stress"]
    FLAVONOIDS -.protects against.-> chronic_inflammation["chronic inflammation"]
    FLAVONOIDS -->|"regulates"| BCL2["BCL2"]
    FLAVONOIDS -->|"activates"| apoptosis["apoptosis"]
    FLAVONOIDS -->|"regulates"| IL_1_["IL-1beta"]
    FLAVONOIDS -->|"regulates"| TNF__["TNF-alpha"]
    FLAVONOIDS -->|"inhibits"| Tau_protein_aggregation["Tau protein aggregation"]
    AGING["AGING"] -->|"target for"| FLAVONOIDS
    BDNF["BDNF"] -->|"activates"| FLAVONOIDS
    ERK -->|"activates"| FLAVONOIDS
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"target for"| FLAVONOIDS
    MICROGLIA["MICROGLIA"] -->|"target for"| FLAVONOIDS
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| FLAVONOIDS
    HK2["HK2"] -->|"activates"| FLAVONOIDS
    AMPK["AMPK"] -->|"activates"| FLAVONOIDS
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| FLAVONOIDS

Outgoing (381)

Target	Relation	Type	Str
Als	therapeutic_target	disease	0.85
Inflammation	therapeutic_target	disease	0.85
Neurodegeneration	therapeutic_target	disease	0.85
Cancer	therapeutic_target	disease	0.85
Als	regulates	disease	0.85
Aging	treats	disease	0.85
Als	associated_with	disease	0.85
ERK	regulates	gene	0.80
MAPK	modulates	pathway	0.80
Apoptosis	therapeutic_target	pathway	0.80
Als	activates	disease	0.75
Fibrosis	inhibits	disease	0.75
Inflammation	inhibits	disease	0.75
Parkinson	therapeutic_target	disease	0.75
Neuroinflammation	therapeutic_target	disease	0.75
Ischemia	therapeutic_target	disease	0.75
Neuroinflammation	activates	disease	0.75
Inflammation	activates	disease	0.75
Tumor	regulates	disease	0.75
Cardiovascular	treats	disease	0.75
Oxidative Stress	associated_with	pathway	0.70
NEUROINFLAMMATION	therapeutic_target	gene	0.70
CANCER	therapeutic_target	gene	0.70
Apoptosis	activates	pathway	0.70
NEUROINFLAMMATION	activates	gene	0.70
Nf-Κb	regulates	pathway	0.70
Blood-Brain Barrier	therapeutic_target	pathway	0.70
Oxidative Stress	therapeutic_target	pathway	0.70
Aging	therapeutic_target	disease	0.65
Epilepsy	interacts_with	disease	0.65
Alzheimer	activates	disease	0.65
Anxiety	associated_with	disease	0.65
Ms	activates	disease	0.65
Ms	associated_with	disease	0.65
Multiple Sclerosis	activates	disease	0.65
ALS	activates	disease	0.65
Parkinson	activates	disease	0.65
Amyotrophic Lateral Sclerosis	activates	disease	0.65
Neurodegeneration	activates	disease	0.65
ALS	associated_with	disease	0.65
Carcinoma	causes	disease	0.65
Cancer	causes	disease	0.65
Cardiovascular	associated_with	disease	0.65
Parkinson	regulates	disease	0.65
Alzheimer	regulates	disease	0.65
Neurodegeneration	regulates	disease	0.65
Cancer	regulates	disease	0.65
Aging	regulates	disease	0.65
Psoriasis	regulates	disease	0.65
Inflammation	regulates	disease	0.65

Incoming (198)

Source	Relation	Type	Str
PARKINSON'S DISEASE	therapeutic_target	gene	0.70
OXIDATIVE STRESS	associated_with	gene	0.70
NF-ΚB	regulates	gene	0.70
NEURODEGENERATION	therapeutic_target	gene	0.70
AMPK	therapeutic_target	gene	0.70
AKT	treats	gene	0.70
OXIDATIVE STRESS	therapeutic_target	gene	0.70
APOPTOSIS	therapeutic_target	gene	0.70
AGING	therapeutic_target	gene	0.60
BDNF	activates	gene	0.60
ERK	activates	gene	0.60
MICROGLIA	therapeutic_target	gene	0.60
ALZHEIMER'S DISEASE	activates	gene	0.60
HK2	activates	gene	0.60
AMPK	activates	gene	0.60
MICROGLIA	activates	gene	0.60
NEURODEGENERATIVE DISEASES	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
ALS	activates	gene	0.60
LYSOSOME	therapeutic_target	gene	0.60
GENES	therapeutic_target	gene	0.60
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	0.60
DNAJC6	therapeutic_target	gene	0.60
VPS35	therapeutic_target	gene	0.60
SYNAPSE	therapeutic_target	gene	0.60
SH3GL2	therapeutic_target	gene	0.60
ROS	therapeutic_target	gene	0.60
ROS	activates	gene	0.60
NEURODEGENERATION	regulates	gene	0.60
PARKINSON'S DISEASE	regulates	gene	0.60
OXIDATIVE STRESS	regulates	gene	0.60
PI3K	regulates	gene	0.60
PARKINSON	regulates	gene	0.60
ALZHEIMER	regulates	gene	0.60
NEURODEGENERATIVE DISEASES	regulates	gene	0.60
NRF2	regulates	gene	0.60
AKT	regulates	gene	0.60
TNF	regulates	gene	0.60
IL-6	regulates	gene	0.60
INFLAMMATION	regulates	gene	0.60
TLR	regulates	gene	0.60
CANCER	regulates	gene	0.60
TNF-Α	regulates	gene	0.60
HK2	therapeutic_target	gene	0.60
PARKINSON	therapeutic_target	gene	0.60
ALZHEIMER	therapeutic_target	gene	0.60
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	0.60
ALS	therapeutic_target	gene	0.60
ALZHEIMER'S DISEASE	therapeutic_target	gene	0.60
AGING	treats	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

FLAVONOIDS

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Parkinson's Disease

Device Therapies Comparison for CBS/PSP

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Neuroresilience Mechanisms and Evidence

Neuroimmune Response in 4R-Tauopathies: Cross-Disease Comparison

amyloid-beta-metalloproteinases

Mitophagy Pathway in Neurodegeneration

GBA Pathway in Parkinson's Disease

Protein Aggregation Comparison in Neurodegeneration

Mediterranean and MIND Diets for Neurodegeneration

proteasome-ubiquitin-system-dysfunction-parkinsons

Microglial Senescence Pathway in Neurodegeneration

Genistein for Mild Cognitive Impairment (NCT07385937)

Notch Signaling Pathway in Neurodegeneration

Amyloid-beta Fibril Formation Pathway

Neurogenesis

Cellular Senescence in Neurodegeneration